Melodiol inks deal to sell Mernova facility to wipe out debts by Steve Jones July 23, 2024July 23, 2024 Melodiol Global Health has agreed to sell its Mernova facility in Canada for up to A$14.2 […]
Melodiol ponders options amid ‘challenging and volatile capital markets’ by Steve Jones June 19, 2024June 19, 2024
Health House to open its own telehealth clinic this quarter by Martin Lane April 9, 2024July 16, 2024
Health House parent becomes latest to report financial woes despite revenue growth by Steve Jones March 4, 2024March 6, 2024
Company news: Bioxyne/BLS; Wellnex Life; Elixinol Wellness; Althea; Health House; Rua Bioscience by Steve Jones and Martin Lane February 7, 2024February 7, 2024
Melodiol flags possible sale of core assets to raise capital by Steve Jones December 11, 2023December 13, 2023
Health House International delivers profitable quarter for new owner Melodiol by Martin Lane October 16, 2023April 30, 2024
Melodiol reports strong start to Q3 as Health House acquisition begins to bed down by Steve Jones July 19, 2023April 30, 2024
Creso Pharma eyes Australian market as firm seeks GMP licence by Steve Jones June 6, 2023April 30, 2024
Company news: Asterion; Ecofibre; Avecho; Epsilon Healthcare; Creso Pharma; Cann Global by Martin Lane and Steve Jones May 18, 2023April 30, 2024
